REQUEST A DEMO
Total
USD $0.00
Search more companies

Research Medicine Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Research Medicine Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Research Medicine Private Limited is an enterprise based in India. Its main office is in North West Delhi. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on September 27, 2002. In 2025, the company reported a net sales revenue drop of 1.53%. There was a total growth of 2.56% in Research Medicine Private Limited’s total assets over the same period. The net profit margin of Research Medicine Private Limited decreased by 0.1% in 2025.

Legal Address
A-306, Phase-1 Vijay Vihar
North West Delhi; Delhi; Postal Code: 110085

Contact Details: Purchase the Research Medicine Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Research Medicine Private Limited report to view the information.
Financial Auditors:
Purchase the Research Medicine Private Limited report to view the information.
Incorporation Date:
September 27, 2002
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Research Medicine Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-1.53%
Total Operating Revenue
-1.5%
Operating Profit
37.13%
EBITDA
23.13%
Net Profit/Loss for the Period
-29.1%
Total Assets
2.56%
Total Equity
0.58%
Operating Profit Margin
1.54%
Net Profit Margin
-0.1%
Return on Equity (ROE)
-0.24%
Debt / Equity
-5%
Quick Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?